Navigation Links
St. Jude Study Shows Effectiveness of Peramivir in Prevention of,Mortality in Mouse Model of Avian Influenza H5N1 Virus Infection

nfluenza, including human influenza due to strains of avian origin. We wish to congratulate our colleagues at St. Jude on the successful conduct of an elegant study which not only confirms but significantly extends the observations of the previous animal study reported last year by NIH showing positive effects of peramivir in a similar model of H5N1 influenza virus infection."

BioCryst is advancing the clinical development of peramivir under terms of a contract from the U.S. Department of Health and Human Services (DHHS) which on January 4, 2007 awarded BioCryst a $102.6 million, four-year contract to develop peramivir for the treatment of seasonal and life-threatening influenza. Funding from the contract will support manufacturing of clinical lots, process validation, clinical studies and other product approval requirements needed for U.S. licensure. BioCryst retains 100% development and commercialization rights to peramivir worldwide other than in Japan and Korea where BioCryst recently established strategic partnerships with Shionogi & CO. in Japan, and Green Cross in Korea.

About Peramivir

Peramivir is a member of the class of antiviral agents that inhibit influenza viral neuraminidase, an enzyme that is essential for the spread of influenza virus within the host. Peramivir is an inhibitor of influenza A and B neuraminidases and certain strains of influenza viruses that may be resistant to available neuraminidase inhibitors are susceptible to peramivir in laboratory tests. At the 46th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy in September, 2006, data were presented showing that injectable formulations of peramivir were safely administered to healthy subjects at daily doses up to approximately 600 mg. At the same meeting, animal data were presented showing peramivir promoted survival in animals infected with highly pathogenic strains of the H5N1 virus. Peramivir injection has received Fast Track designation f
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:12/17/2014)... Revenue and earnings above the previous year - ... In the past 2013/14 fiscal year (ended 30 September ... 4.287 billion (last year: EUR 4.190 billion) despite unfavorable currency ... million. "Overall, 2013/14 was a successful fiscal year for the ... CEO of Carl Zeiss AG. "Thanks to our broad portfolio ...
(Date:12/17/2014)... Ariz. , Dec. 17, 2014  Beamz ... state-of-the-art interactive music products, today announced that it ... a leading manufacturer and supplier of innovative prosthetic, ... As part of the agreement, RSL Steeper ... bundled solution specifically configured for use within UK ...
(Date:12/17/2014)... Dec. 17, 2014  RXi Pharmaceuticals Corporation (NASDAQ: ... on discovering, developing and commercializing innovative therapies addressing ... completion of enrollment in its first Phase 2a ... observations confirmed the 1-month findings that were reported ... Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO , ...
Breaking Medicine Technology:ZEISS Asserts its Position in Difficult Environment 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5
(Date:12/22/2014)... At the annual National League ... San Antonio, esteemed experts and thought leaders will ... in the way of successful organizational performance: resistance, ... faculty development opportunity is made possible through the ... to assist nurse educators to advance to leadership ...
(Date:12/21/2014)... In this report, the global powered ... product, and application. The market, by power source, ... By product, the market covers the handpieces; power ... market is further subdivided into drills, saws, reamers, ... shavers, wire/pin drivers, and others. Moreover, the power ...
(Date:12/21/2014)... Weddingshe.com, an outstanding online supplier of wedding dresses ... new selection of Cocktail Dresses for the winter 2014. ... newest fashion trends. , “We take pride ... . All of them are offered at greatly discounted ... every effort to offer a nice shopping experience for ...
(Date:12/21/2014)... (PRWEB) December 21, 2014 Khanna Vision ... a guest at the Aspen Helicopters holiday event for ... a Santa with sleigh, flown by an aspen helicopter ... invisible; only Santa with sleigh was visible.(please see accompanying ... and night. Dr.Khanna has helped many pilots with Pi ...
(Date:12/21/2014)... (PRWEB) December 21, 2014 AngelWeddingDress.com’s new ... There is a total of 1,000 new designs in ... the coming spring 2015. , AngelWeddingDress.com promises ... female shoppers with wardrobe essentials while many fashion trends ... problems, the customer service team at AngelWeddingDress.com is ready ...
Breaking Medicine News(10 mins):Health News:2015 NLN Leadership Conference February 5-7 San Antonio 2Health News:2015 NLN Leadership Conference February 5-7 San Antonio 3Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 2Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 3Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 4Health News:Stunning Cocktail Party Dresses from Weddingshe.com 2Health News:2015 Spring Wedding Dresses From AngelWeddingDress Just Released 2
... results across MDS, TORONTO, Sept. 6 /PRNewswire-FirstCall/ ... providing products and services to the global life ... For the quarter,MDS reported revenues of $321 million, ... from continuing operations of $0.07. Adjusted EBITDA,rose to ...
... product a proven treatment -, BELLEVILLE, ON, ... BNC), a research-based, technology-driven Canadian,biopharmaceutical company, today announced ... Australia in order to be able to respond ... continent,s equine influenza outbreak.,The outbreak began in August, ...
... N.Y., Sept. 6 /PRNewswire/, Who: Breast Cancer patients, survivors and ... (a breast cancer support center) on Thursday, September 6, What: ... ... wheels to encourage them to Keep ... to give cancer patients, survivors and caregivers a much needed ...
... Fairbank Farms, a national,ground beef producer, is ... Beef Patties. The ground beef patties, sold fresh,under ... consumers in New,England on Wednesday September 5, 2007 ... of caution, the product has been removed from ...
... Va., Sept. 5 AMERIGROUP,Corporation (NYSE: AGP ) ... Corporation have approved the sale of its assets,including TLC ... subject to regulatory approval by the State of Tennessee. ... of 2007. TLC Family Care Health Plan serves ...
... YORK, Sept. 5 Belfast Merger Co., a,wholly owned ... the expiration date for its cash tender offer for ... Inc. (Nasdaq: DADE ). The,tender offer has been ... September 26, 2007. The tender offer is being made ...
Cached Medicine News:Health News:MDS Reports Third Quarter 2007 Results 2Health News:MDS Reports Third Quarter 2007 Results 3Health News:MDS Reports Third Quarter 2007 Results 4Health News:MDS Reports Third Quarter 2007 Results 5Health News:MDS Reports Third Quarter 2007 Results 6Health News:MDS Reports Third Quarter 2007 Results 7Health News:MDS Reports Third Quarter 2007 Results 8Health News:MDS Reports Third Quarter 2007 Results 9Health News:MDS Reports Third Quarter 2007 Results 10Health News:MDS Reports Third Quarter 2007 Results 11Health News:MDS Reports Third Quarter 2007 Results 12Health News:MDS Reports Third Quarter 2007 Results 13Health News:MDS Reports Third Quarter 2007 Results 14Health News:MDS Reports Third Quarter 2007 Results 15Health News:MDS Reports Third Quarter 2007 Results 16Health News:MDS Reports Third Quarter 2007 Results 17Health News:MDS Reports Third Quarter 2007 Results 18Health News:MDS Reports Third Quarter 2007 Results 19Health News:MDS Reports Third Quarter 2007 Results 20Health News:MDS Reports Third Quarter 2007 Results 21Health News:MDS Reports Third Quarter 2007 Results 22Health News:MDS Reports Third Quarter 2007 Results 23Health News:MDS Reports Third Quarter 2007 Results 24Health News:MDS Reports Third Quarter 2007 Results 25Health News:MDS Reports Third Quarter 2007 Results 26Health News:MDS Reports Third Quarter 2007 Results 27Health News:MDS Reports Third Quarter 2007 Results 28Health News:MDS Reports Third Quarter 2007 Results 29Health News:MDS Reports Third Quarter 2007 Results 30Health News:MDS Reports Third Quarter 2007 Results 31Health News:MDS Reports Third Quarter 2007 Results 32Health News:MDS Reports Third Quarter 2007 Results 33Health News:Bioniche Responds to Australian Equine Influenza Outbreak 2Health News:Bioniche Responds to Australian Equine Influenza Outbreak 3Health News:New York City Cancer Patients, Survivors and Care Givers Encouraged to Keep Going(R) 2
Icefire has ice crystals on the top of a cool blue iris....
This pattern transform your pupils into narrow slits surrounded by eye stopping yellow. Works well with kitty-cat costumes....
Silicone tip cannula angled at 7 mm, sterile, disposable (bx/10)....
Maumenee vitreous aspirating cannula, 18 gauge....
Medicine Products: